细菌感染是与伤口治疗相关的常见问题,其对医疗保健系统和患者施加显著负担。因此,医疗保健提供者迫切需要新的治疗策略来保护人们。具有固有抗微生物特性的水凝胶生物材料为该问题提供了有吸引力且可行的解决方案。这里,第一次,我们开发了一种新的有效的合成策略,通过使用缩合反应将反式-1,4-环己烷二胺与1,3-二溴-2-丙醇化学交联,而无需使用有毒的交联剂,来制备具有固有高效抗菌性能的阳离子水凝胶(PHCI)。不出所料,制备的PHCI水凝胶具有固有的抗菌能力,可以静电吸附和杀灭金黄色葡萄球菌和大肠杆菌。值得注意的是,在正常和糖尿病大鼠模型上的体内实验证实,PHCI水凝胶可以快速止血,有效地杀死细菌,促进巨噬细胞从促炎M1表型转化为修复的M2表型,加速胶原沉积和血管形成,从而实现伤口的快速愈合。总的来说,这项工作提出了一种有效的抗菌敷料,可能为临床伤口管理提供一种简便但有效的方法。
Bacterial infections are a common problem associated with wound treatment that imposes a significant burden on healthcare systems and patients. As a result, healthcare providers urgently need new treatment strategies to protect people. Hydrogel biomaterials with inherent antimicrobial properties offer an attractive and viable solution to this issue. Here, for the first time, we have developed a new efficient synthetic strategy to prepare cationic hydrogels (PHCI) with intrinsically efficient antimicrobial properties by chemically cross-linking trans-1,4-cyclohexanediamine with 1,3-dibromo-2-propanol using a condensation reaction without the use of toxic cross-linking agents. As expected, the prepared PHCI hydrogel possessed an inherent antibacterial ability that can adsorb and kill Staphylococcus aureus and Escherichia coli electrostatically. Notably, in vivo experiments on normal and diabetic rat models confirmed that the PHCI hydrogel can quickly stop bleeding, efficiently kill bacteria, promote the conversion of macrophages from the proinflammatory M1 phenotype to the repaired M2 phenotype, and accelerate collagen deposition and blood vessel formation, thereby achieving rapid wound healing. Overall, this work presents an effective antibacterial dressing that might provide a facile but effective approach for clinical wound management.